Total Payments
$72,062
2023 Payments
$103.72
Companies
11
Transactions
49
Medicare Patients
2,162
Medicare Billing
$308,777
Payment Breakdown by Category
Other$70,060 (97.2%)
Food & Beverage$1,201 (1.7%)
Travel$626.05 (0.9%)
Education$173.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $70,000 | 5 | 97.1% |
| Food and Beverage | $1,201 | 36 | 1.7% |
| Travel and Lodging | $626.05 | 3 | 0.9% |
| Education | $173.90 | 2 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60.43 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $51,435 | 30 | $0 (2019) |
| Boston Scientific Corporation | $20,161 | 3 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $110.25 | 1 | $0 (2018) |
| ARGENX US, INC. | $103.72 | 1 | $0 (2023) |
| Acorda Therapeutics, Inc | $60.43 | 3 | $0 (2019) |
| Abbott Laboratories | $58.99 | 3 | $0 (2021) |
| Biogen, Inc. | $52.54 | 3 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $31.54 | 2 | $0 (2022) |
| Medtronic, Inc. | $22.43 | 1 | $0 (2022) |
| Merz North America, Inc. | $13.60 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $103.72 | 1 | ARGENX US, INC. ($103.72) |
| 2022 | $41.78 | 2 | Medtronic, Inc. ($22.43) |
| 2021 | $42.38 | 3 | Biogen, Inc. ($16.13) |
| 2020 | $36.41 | 2 | Biogen, Inc. ($36.41) |
| 2019 | $6,650 | 11 | Medtronic USA, Inc. ($6,403) |
| 2018 | $45,418 | 16 | Medtronic USA, Inc. ($25,262) |
| 2017 | $19,770 | 14 | Medtronic USA, Inc. ($19,770) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $103.72 | General |
| Category: Immunology | ||||||
| 10/22/2022 | Medtronic, Inc. | SENSIGHT (Device) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 01/20/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Rare Disease | ||||||
| 12/10/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
| 09/22/2021 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuromodulation | ||||||
| 08/27/2020 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: NEUROLOGY | ||||||
| 08/19/2020 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, VUMERITY | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2019 | Boston Scientific Corporation | GENERAL DBS (Device) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: DBS | ||||||
| 08/22/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: PARKINSONS DISEASE | ||||||
| 08/21/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21.32 | General |
| Category: PARKINSONS DISEASE | ||||||
| 05/22/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Grant | Cash or cash equivalent | $6,250.00 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 05/21/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $19.11 | General |
| Category: PARKINSONS DISEASE | ||||||
| 04/04/2019 | Boston Scientific Corporation | GENERAL DBS (Device) | Food and Beverage | In-kind items and services | $135.12 | General |
| Category: DBS | ||||||
| 04/04/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| Category: MUSCULOSKELETAL | ||||||
| 03/02/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $40.28 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 02/26/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $43.52 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 02/23/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $69.36 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/14/2018 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/19/2018 | Medtronic USA, Inc. | ACTIVA (Device) | Grant | Cash or cash equivalent | $18,750.00 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 09/13/2018 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/15/2018 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 07/25/2018 | BOSTON SCIENTIFIC CORPORATION | SPECTRA WAVEWRITER (Device) | Grant | Cash or cash equivalent | $20,000.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/10/2018 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 601 | 11,994 | $488,210 | $122,682 |
| 2022 | 8 | 585 | 5,439 | $340,449 | $82,005 |
| 2021 | 7 | 538 | 723 | $243,091 | $59,280 |
| 2020 | 7 | 438 | 553 | $197,292 | $44,810 |
Total Patients
2,162
Total Services
18,709
Medicare Billing
$308,777
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 11,185 | $212,515 | $55,418 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 422 | $118,246 | $28,023 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 179 | $75,201 | $18,393 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $33,234 | $8,499 | 25.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 17 | 40 | $22,815 | $6,075 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $17,127 | $4,392 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 48 | $9,072 | $1,881 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 404 | $118,328 | $27,647 | 23.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 16 | 4,645 | $86,896 | $22,002 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 107 | 139 | $58,976 | $14,479 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $41,323 | $9,687 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 80 | $16,696 | $3,708 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $14,148 | $3,483 | 24.6% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2022 | 14 | 28 | $2,128 | $522.21 | 24.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 14 | 14 | $1,954 | $477.15 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 291 | $85,451 | $21,228 | 24.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 97 | 146 | $62,341 | $14,463 | 23.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 112 | 112 | $44,671 | $10,937 | 24.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 57 | 57 | $30,419 | $7,330 | 24.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 81 | $16,718 | $4,382 | 26.2% |
| 11105 | Punch biopsy of additional skin lesion | Office | 2021 | 11 | 24 | $1,812 | $489.36 | 27.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 11 | 12 | $1,679 | $450.48 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 115 | 196 | $57,264 | $12,901 | 22.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 127 | 127 | $59,324 | $12,469 | 21.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 47 | 47 | $27,684 | $6,441 | 23.3% |
About Dr. Daniel Savitt, D.O
Dr. Daniel Savitt, D.O is a Neurology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992149603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Savitt, D.O has received a total of $72,062 in payments from pharmaceutical and medical device companies, with $103.72 received in 2023. These payments were reported across 49 transactions from 11 companies. The most common payment nature is "Grant" ($70,000).
As a Medicare-enrolled provider, Savitt has provided services to 2,162 Medicare beneficiaries, totaling 18,709 services with total Medicare billing of $308,777. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Scottsdale, AZ
- Active Since 04/24/2013
- Last Updated 01/11/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992149603
Products in Payments
- ACTIVA (Device) $51,435
- SPECTRA WAVEWRITER (Device) $20,000
- GENERAL DBS (Device) $160.64
- VYVGART (Drug) $103.72
- INBRIJA (Drug) $60.43
- Infinity DBS Pulse Generators (Device) $58.99
- SENSIGHT (Device) $22.43
- VUMERITY (Drug) $21.64
- SOLIRIS (Biological) $19.35
- ADUHELM (Biological) $16.13
- TYSABRI (Biological) $14.77
- XEOMIN (Biological) $13.60
- TEGSEDI (Drug) $12.46
- Soliris (Drug) $12.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Scottsdale
Dr. Nida Laurin, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Amaal Starling, M.d, M.D
Neurology — Payments: $314,467
Neurology $314,467
Dr. Dean Wingerchuk, M.d, M.D
Neurology — Payments: $314,438
Neurology $314,438
Dr. Virgilio Evidente, M.d, M.D
Neurology — Payments: $280,162
Neurology $280,162
David Saperstein, Md, MD
Neurology — Payments: $173,854
Neurology $173,854
Dr. Cornelia Drees, M.d, M.D
Neurology — Payments: $171,652
Neurology $171,652